Sphingosine-1-Phosphate (S1P) Receptor Modulators for the Treatment of Inflammatory Bowel Disease (IBD): Mechanisms, Clinical Evidence, and Practical Insights

Inflammatory bowel disease commonly requires advanced therapies to induce and maintain durable remission. Sphingosine-1-phosphate receptor modulators are the latest class of orally administered small molecules that have been added to the therapeutic armamentarium for inflammatory bowel disease. Thes...

Descrición completa

Detalles Bibliográficos

Principais autores:	Natalie Shields, Michael Colwill, Valentina Raspa, Yaw Twum-Danso, Andrew Poullis, Kamal Patel, Sailish Honap
Formato:	Artigo
Idioma:	Inglês
Publicado:	MDPI AG 2025-10-01
Series:	Biomedicines
Assuntos:	Sphingosine-1-Phosphate (S1P) Receptor Modulators ulcerative colitis Crohn’s disease inflammatory bowel disease clinical trials real world evidence
Acceso en liña:	https://www.mdpi.com/2227-9059/13/11/2655
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!